MIT School of Architecture and Planning

Phillip T. and Susan M. Ragon Institute is a medical institute founded in 2009 at the Massachusetts General Hospital (MGH) by the funding from founder and CEO of InterSystems Phillip Ragon and his wife Susan Ragon to find vaccines for diseases of the immune system, particularly HIV/AIDS. The institute includes scientists from Harvard University, the Massachusetts Institute of Technology (MIT) and the MGH, a level I trauma center which is the largest teaching hospital affiliated with Harvard Medical School. The Phillip T. and Susan M. Ragon Institute, or the Ragon Institute of MGH, MIT and Harvard, was officially established in February 2009 with a dual mission: to contribute to the accelerated discovery of an HIV/AIDS vaccine and subsequently to establish itself as a world leader in the collaborative study of immunology.

Technology Square, nicknamed Tech Square, is a commercial office building complex in the Kendall Square neighborhood of Cambridge, Massachusetts, immediately adjacent to the campus of the Massachusetts Institute of Technology (MIT).

Greene-Rose Heritage Park is a park in Cambridge, Massachusetts, United States. Opened in 2008, the park is located along Harvard Street, near the intersection with Moore Street. It has a playground and tennis courts.

The Josiah Mason Jr. House is a historic house in Cambridge, Massachusetts.

Rufus Lamson House is a historic house in Cambridge, Massachusetts, listed on the National Register of Historic Places in 1982, a few blocks from the Lamson Place. The house was apparently built and owned by Rufus Lamson (October 2, 1809 – July 13, 1879) and then inherited by his widow Mary Jane Lamson (Butler) (1812 – 1885) whom he married at Boston, on Thanksgiving Eve, 1832. Rufus Lamson was a stonemason and a large holder of real estate, known for his liberal treatment of the landlord and tenant relation. He was a member of the Universalist Church in Cambridge and served as an assessor for the city for twenty-two years.Rufus Lamson and his son, Rufus William Lamson (1833–1912) ran a firm Rufus Lamson & Son that built many of the substantial brick structures now standing in Cambridgeport. Asa Caleb Lamson (1848 - 1924), the youngest son of Rufus Lamson, has completed in 1908 a 5-story mansion located at 351 Massachusetts Avenue in Cambridge, MA, called The Lamson, presently occupied by Lambda Phi chapter of Alpha Delta Phi of MIT.

Moderna, Inc., ( mə-DUR-nə) is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to produce an immune response.The company's only commercial product is the Moderna COVID-19 vaccine. As of 2022, the company has 44 treatment and vaccine candidates, of which 21 have entered clinical trials. Targets for vaccine candidates include influenza, HIV, respiratory syncytial virus, Epstein–Barr virus, the Nipah virus, chikungunya, a combined single-shot COVID-19 booster and influenza vaccine, a cytomegalovirus vaccine, and two cancer vaccines. The company's pipeline also includes candidates for cancer immunotherapy using OX40 ligand, interleukin 23, IL36G, and interleukin 12 as well as, in partnership with AstraZeneca, a regenerative medicine treatment that encodes vascular endothelial growth factor A to stimulate blood vessel growth for patients with myocardial ischemia.

The George Close Company BUilding is an historic industrial building at 243 Broadway in Cambridge, Massachusetts. Built in 1910 for a candy manufacturer, it is a good local example of industrial Classical Revival architecture, and was converted to residential use in 1976. The building was added to the National Register of Historic Places in 2019.

The Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology, Cambridge, Massachusetts, United States, engages in fundamental research in the areas of brain and neural systems, and cognitive processes. The department is within the School of Science at the MIT and began initially as the Department of Psychology founded by the psychologist Hans-Lukas Teuber in 1964. In 1986 the MIT Department of Psychology merged with the Whittaker College integrating Psychology and Neuroscience research to form the Department of Brain and Cognitive Sciences.

The Picower Institute for Learning and Memory is, along with the McGovern Institute for Brain Research and the Department of Brain and Cognitive Sciences, one of the three neuroscience groups at MIT. The institute is focused on studying all aspects of learning and memory; specifically, it has received over US$50 million to study Alzheimer's, schizophrenia and similar diseases. When it was established in 1994, the institute was primarily funded by the Sherman Fairchild Foundation, the RIKEN Brain Science Institute and the National Institute of Mental Health. It was renamed after a $50 million grant by the Picower Foundation in 2002.On July 1, 2009, Professor Li-Huei Tsai became the director of the Picower Institute. The institute was directed by founder and Nobel Prize laureate Susumu Tonegawa until he resigned on December 31, 2006, motivated by his belief that “a new generation of leadership is needed.”

The McGovern Institute for Brain Research is a research institute within MIT. Its mission is to understand how the brain works and to discover new ways to prevent or treat brain disorders. The institute was founded in 2000 by Patrick McGovern and Lore Harp McGovern with a gift to MIT that is expected to total $350M over 20 years.

Hungry Mother was a restaurant in Cambridge, Massachusetts, United States. Rachel Miller Munzer won in the Best Host category of Boston magazine's Best of Boston poll in 2009. Hungry Mother closed in 2015.

Lab Central, Inc., also known as LabCentral, is a non-profit organization started in November 2013. LabCentral built a shared laboratory facility in Kendall Square, Cambridge, Massachusetts that offers fully permitted laboratory and office space for approximately 60 emerging biotech companies where controlled conditions in which scientific research, experiments, and measurement may be performed. As a non-profit, LabCentral does not take equity in any of its companies. Its main sources of funding are revenues from user fees, as well as grants and sponsorship contributions. LabCentral officially opened on April 1, 2014.